Case report reveals severe coagulopathy due to vitamin K deficiency in a patient with cancer cachexia, indicating crucial clinical implications.
Vitamin K deficiency is a well recognized cause of acquired coagulopathy, but its presentation as severe coagulopathy in the setting of advanced malignancy is not well described. We report a 67-year-old man with recurrent metastatic urothelial carcinoma and severe cachexia who presented with a markedly prolonged prothrombin time (PT) of 105.8 s and activated partial thromboplastin time (APTT) of 58.2 s. Hematologic evaluation revealed deficiencies in vitamin K-dependent clotting factors, and his coagulopathy corrected with intravenous vitamin K replacement. This case highlights that cancer cachexia itself can precipitate clinically significant vitamin K deficiency in patients with advanced malignancy leading to severe coagulopathy.
No takes yet. Share an insight, caveat, or question.
Balusu et al. (2026) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: